HOXA9 and central nervous system neoplasm: Additionally, using the Methylation Outlier Detector program, other studies identified eight methylated markers that allowed the development of a new test to distinguish PCNSL from other CNS tumors [51] and the early detection and monitoring of cerebral B-cell lymphomas by following markers such as HOXA9 and GABRG3 [52].